FEATURES OF LABORATORY INDICATORS OF IRON METABOLISM AT PATIENTS WITH CO-INFECTION: TUBERCULOSIS AND HEPATITIS C



Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The aim of the research was to study the metabolism of iron at patients with co-infection: tuberculosis of the respiratory organs and chronic hepatitis C. Simple randomized research. The main group consists of patients suffering with chronic viral hepatitis C and respiratory tuberculosis (n=71). The control group consists of patients with respiratory tuberculosis (n=128). The main indicators of hemogram, iron metabolism and acute phase proteins were defined. Indicators in the groups were assessed using the nonparametric Mann-Whitney test. Among the patients in the control group, anemia was detected at 25% of the patients. In the experimental group this rate amounted to 26.7%. In the main group, there was a statistically significant difference in the mean volume of erythrocytes, higher values of ferritin, serum iron, and value of saturation of transferrin with iron in per cents. In the case of chronic forms of tuberculosis in the control group, the concentration of hemoglobin decreased, reticulocytosis appeared, serum iron concentration and percentage of saturation of transferrin by iron decreased. In the experimental group, these indicators remained at a high level. The differences in the groups were statistically significant. At patients suffering with chronic v iral hepatitis C and respiratory tuberculosis, a more frequent progression of anemia in chronic form of the disease was detected, followed by a tendency to overload the tissues with iron. At the same time, among patients with chronic forms of tuberculosis and hepatitis, much less cases of anemia appear.

Full Text

Restricted Access

About the authors

D N Oskin

Ryazan State Medical University named after academician I.P. Pavlov

A N Varnavsky

Ryazan State Radio Engineering University

References

  1. Миронов А.Ю., Леонов В.В. Железо, вирулентность и межмикробные взаимодействия условно-патогенных микроорганизмов // Успехи современной биологии. 2016. Т. 136, № 3. С. 301-310. [Mironov A.Yu., Leonov V.V. Iron, virulence and intermicrobial interactions of opportunistic microorganisms, Advances in modern biology. 2016. Vol. 136, N 3. Р. 301-310.]
  2. Николаев А.Н. Профилактика послеоперационной анемии у больных туберкулёзом // Российский медико-биологический вестник им. академика И.П. Павлова. 2014. № 2. С. 61-67. [Nikolaev A.N. Prevention of postoperative anemia in patients with tuberculosis, Russian medico-biological bulletin name academician I.P. Pavlova. 2014. N 2. P. 61-67.]
  3. Инякова Н.В. Распространенность и методы коррекции нарушений обмена железа при туберкулезной инфекции: автореф. дис. ... канд. мед. наук. Федеральный научно-клинический центр детской гематологии, онкологии и иммунологии Росздрава. Рязань, 2011. 26 с. [Inyakova N.V. Prevalence and methods of correction of iron metabolism disorders in tuberculosis infection. Ryazan, 2011. 26 p.]
  4. Натальский А.А., Тарасенко С.В., Песков О.Д. Проблема печеночной недостаточности в хирургии // Наука Молодых - Eruditio Juvenium. 2013. № 1. С. 59-71. [Natal'skii A.A., Tarasenko S.V., Peskov O.D. The problem of hepatic insufficiency in surgery // Science of Young - Eruditio Juvenium. 2013. N 1. P. 59-71.]
  5. Николаев А.Н. Результаты использования рекомбинантного человеческого эритропоэтина и сахарата железа для профилактики послеоперационной анемии у больных туберкулезом // Земский врач. 2015. № 1 (25). С. 37-41. [Nikolaev A.N. Results of the use of recombinant human erythropoietin and iron saccharate for the prevention of postoperative anemia in patients with tuberculosis, Zemsky Doctor. 2015. N 1 (25). P. 37-41.]
  6. Иванов А.К., Сакра А.А., Нечаев В.В., Малашёнков Е.А., Назаров В.Ю., Шевырёва Е.В. Сочетание туберкулеза и вирусных гепaтитов: старые и новые проблемы // Профилактическая и клиническая медицина. 2013. № 3 (48). С. 78-81. [Ivanov A.K., Sacra A.A., Nechaev V.V., Malashenko E.A., Nazarov V.Y., Shevyreva E.V. The combination of tuberculosis and viral hepatitis: old and new problems, Prophylactic and Clinical Medicine. 2013. No. 3 (48). P. 78-81.]
  7. Oliveira Uehara de S.N., Emori Ch.T., Perez R.M., Mendes-Correa M.C.J. et al. High incidence of tuberculosis in patients treated for hepatitis C chronic infection // The Brazilian Journal of Infectious Diseases. 2016. Vol. 20, Issue 2. P. 205-209.
  8. Beijer U., Wolf A., Fazel S. Prevalence of tuberculosis, hepatitis C virus, and HIV in homeless people: a systematic review and meta-analysis // The Lancet Infectious Diseases. 2012. Vol. 12, Issue 11. P. 859-870.
  9. Matthews Ph.C., Geretti A.M., Goulder Ph.J.R., Klenerman P. Epidemiology and impact of HIV coinfection with Hepatitis B and Hepatitis C viruses in Sub-Saharan Africa // Journal of Clinical Virology. 2014. Vol. 61, Issue 1. P. 20-33.
  10. Kamarulzaman A., Reid S.E., Schwitters A., Wiessing L. et al. Prevention of transmission of HIV, hepatitis B virus, hepatitis C virus, and tuberculosis in prisoners // The Lancet. 2016. Vol. 388, Issue 10049. P. 1115-1126.
  11. Agha M.A., El-Mahalawy I.I., Seleem H.M., Helwa M.A. Prevalence of hepatitis C virus in patients with tuberculosis and its impact in the incidence of anti-tuberculosis drugs induced hepatotoxicity // Egyptian Journal of Chest Diseases and Tuberculosis. 2015. Vol. 64, Issue 1. P. 91-96.
  12. Mo P., Zhu Qi, Teter С., Yang R., Deng L., Yan Y., Chen J., Zeng J., Gui X. Prevalence, drug-induced hepatotoxicity, and mortality among patients multi-infected with HIV, tuberculosis, and hepatitis virus // International Journal of Infectious Diseases. 2014. Vol. 28. P. 95-100.
  13. ВОЗ. Концентрация гемоглобина для диагностики анемии и оценки ее тяжести. Женева, Всемирная организация здравоохранения, 2011. Имеется по адресу: http://www.who.int/vmnis/indicators/haemoglobin_ru.pdf [WHO. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. World Health Organization, 2011. Available from: http://apps.who.int//iris/bitstream/10665/85839/3/WHO_NMH_NHD_MNM_11.1_eng.pdf]
  14. Munoz M., Garcıa-Erce J.A., Remacha A.F. Disorders of iron metabolism. Part II: iron deficiency and iron overload // J. Clin. Pathol. 2011. Vol. 64. Р. 287-296.
  15. Rampton D., Folkersen J., Fishbane S. et al. Hypersensitivity reactions to intravenous iron: guidance for risk minimization and management // Haematologica [Internet]. 2014. Vol. 99. Р. 1671-1676. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25420283.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2017 Oskin D.N., Varnavsky A.N.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 74760 от 29.12.2018 г.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies